Market revenue in 2024 | USD 1,052.3 million |
Market revenue in 2030 | USD 1,943.0 million |
Growth rate | 10.7% (CAGR from 2025 to 2030) |
Largest segment | Cartridges |
Fastest growing segment | Vials |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Vials, Prefilled Syringes, Cartridges |
Key market players worldwide | Boehringer Ingelheim, Catalent Inc, Baxter International Inc, Eurofins Scientific SE, Recipharm, Fresenius SE & Co KGaA, Novartis AG ADR, Recro Pharma, Symbiosis Pharmaceutical Services, MabPlex International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fill-finish pharmaceutical contract manufacturing market will help companies and investors design strategic landscapes.
Cartridges was the largest segment with a revenue share of 27.35% in 2024. Horizon Databook has segmented the Japan fill-finish pharmaceutical contract manufacturing market based on vials, prefilled syringes, cartridges covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is one of the largest pharmaceutical markets in the world. As per estimates by the International Trade Administration, pharmaceutical production in the country accounted for USD 107 billion in 2020. This is attributed to the growing demand for pharmaceuticals in the country amid a rising disease burden.
The significant production of pharmaceuticals in the country is contributing to the demand for CMOs in Japan. The CMOs in the country are expanding their facilities to increase drug production. For instance, in August 2020, Japan-based CMO Bushu Pharmaceutical stated its plans to invest USD 100 million in expanding its Tokyo facility with the addition of eight new packaging lines. The adoption of such strategies by CMOs is expected to boost the market in Japan.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan fill-finish pharmaceutical contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Japan fill-finish pharmaceutical contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account